Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The genetics of statin-induced myopathy.

Atherosclerosis - 1 Jun 2010

Ghatak Abhijit, Faheem Osman, Thompson Paul D

Abstract excerpt

OBJECTIVE: Our goal was to use genetic variants to identify factors contributing to the muscular side effects of statins. BACKGROUND: Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are usually well tolerated medications, but muscle symptoms, ranging from mild myalgia to clinically important rhabdomyolysis are an important side effect of these drugs and a leading cause of noncompliance....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytochrome P-450 Enzyme System
Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors
Share to Liver-Specific Organic Anion Transporter 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Muscles

Share to Muscular Diseases

Share to Muscular Dystrophies

Share to Organic Anion Transporters

Share to Rhabdomyolysis

Source

Identifiers

PMID: 20042189
DOI: 10.1016/j.atherosclerosis.2009.11.033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The genetics of statin-induced myopathy.PMID 20042189Read ↗

Genetic predisposition to statin myopathy.Semantic proximity Read ↗

Statin myotoxicity: a review of genetic susceptibility factors.Semantic proximity Read ↗

Statin-associated myopathy: from genetic predisposition to clinical management.Semantic proximity Read ↗

Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review.Semantic proximity Read ↗

Pharmacogenomic insights into treatment and management of statin-induced myopathySemantic proximity Read ↗

Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.Semantic proximity Read ↗

Genetic predisposition to atorvastatin-induced myopathy: a case report.Semantic proximity Read ↗

Approach to clinical and genetic characterization of statin-induced myopathy.Semantic proximity Read ↗

Genetic risk factors associated with lipid‐lowering drug‐induced myopathiesSemantic proximity Read ↗

Pharmacogenetics of Statin-Induced Myopathy: A Focused Review of the Clinical Translation of Pharmacokinetic Genetic VariantsSemantic proximity Read ↗

Genomewide Association Study of Statin‐Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research DatalinkSemantic proximity Read ↗

Iatrogenic myopathies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.